Table 2. OR and 95% CI between SUA levels and prevalence of vulnerable atherosclerotic carotid plaque.

	SUA
	Quartiles 1	Quartiles 2	Quartiles 3	Quartiles 4	Continuous Scale	p for trend	p interaction
	1.4–4.0 mg/dL	4.1–5.0 mg/dL	5.1–6.0 mg/dL	6.1–14.8 mg/dL
Crude Model	Ref	1.62 (1.32–1.99)	2.12 (1.72–2.62)	2.19 (1.78–2.69)	1.23 (1.17–1.30)	<0.001
Model 11	Ref	1.27 (1.02–1.58)	1.42 (1.13–1.78)	1.41 (1.13–1.78)	1.11 (1.05–1.17)	0.002
Model 22	Ref	1.27 (1.02–1.58)	1.43 (1.14–1.79)	1.42 (1.13–1.78)	1.10 (1.05–1.17)	0.002
Model 33	Ref	1.27 (1.02–1.58)	1.41 (1.12–1.77)	1.37 (1.09–1.74)	1.10 (1.04–1.16)	0.006
Age-stratified analyses							0.017
40–59 (year)4	Ref	1.33 (1.02–1.74)	1.70 (1.27–2.27)	2.05 (1.53–2.75)	1.19 (1.11–1.28)	<0.001
≧ 60 (year)5	Ref	1.02 (0.69–1.52)	0.95 (0.64–1.41)	0.77 (0.52–1.14)	0.97 (0.88–1.06)	0.112

Data expressed by odds ratio (95% confidence interval) and p value.

OR indicates odds ratio; CI, confidence interval.

¹Adjusted for age, sex, smoking status and eGFR.

²Adjusted for age, sex, smoking status, eGFR, diuretics use and statins use.

³Adjusted for age, sex, moderate-to-heavy alcohol use, hypertension, diuretics use, BMI, dyslipidemia and eGFR.

⁴Adjusted for sex, smoking status, eGFR, diuretics use and statins use.

⁵Adjusted for sex, smoking status, eGFR, diuretics use and statins use.